Commodore Capital’s 4D Molecular Therapeutics FDMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-598,385
Closed -$13.3M 35
2022
Q4
$13.3M Buy
+598,385
New +$13.3M 2% 20